

DNA Is Still Where It's At: Christian Henry, CEO of PacBio, on Watershed Year in 2024
Mar 20, 2025
Christian Henry, CEO of Pacific Biosciences, discusses the pivotal role of DNA in genomics and the anticipated launch of the Vega system, a groundbreaking long-read sequencer priced at $169,000. He highlights how this innovation enhances access to long-read sequencing and addresses the pressing concerns over NIH funding and its potential impact on research. Henry is optimistic about the future of genomics, emphasizing the unique discoveries that long reads unlock, including those in epigenetics and disease understanding.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 4min
Revolutionizing Long-Read Sequencing
04:20 • 14min
Advancements in Sequencing Technologies
18:33 • 11min
Navigating Economic Challenges in the Scientific Community
29:22 • 3min
The Crucial Intersection of Genomics and Health
32:31 • 2min
Advancing Bioinformatics: AI Integration and Community Collaboration
34:57 • 4min